News

More than 200 trials to fight COVID-19 worldwide

First patient in PropAngio-trial for angiosarcoma

A publication by scientists of the Anticancer Fund

CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infltrating lymphocytes in ovarian cancer

Christina Friese, Katja Harbst, Troels Holz Borch, Marie Christine Wulff Westergaard, Magnus Pedersen, Anders Kverneland, Göran Jönsson, Marco Donia, Inge Marie Svane, Özcan Met. CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer. Sci Rep. 2020; 10: 3914. Published online 2020 Mar 3. doi: 10.1038/s41598-020-60738-4.

Feedback on Europe's Beating Cancer Plan

Discover our Annual Impact Sheet 2019

How to teach an old medicine new tricks